Catalent Completes Expansion of Clinical Supply Facility in Shanghai, China
December 02, 2022
December 02, 2022
SOMERSET, New Jersey, Dec. 2 -- Catalent Inc., a pharma, biotech and consumer health company, issued the following news:
Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that it has completed the expansion of its clinical supply facility in the Waigaoqiao Free Trade Zone (FTZ) in Shanghai, China.
The project has . . .
Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that it has completed the expansion of its clinical supply facility in the Waigaoqiao Free Trade Zone (FTZ) in Shanghai, China.
The project has . . .